Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
“The neurosurgery devices market is projected to grow at a CAGR of 13.0% during the forecast period.”
The neurosurgery devices market is projected to reach USD 13.5 billion by 2024 from USD 7.3 billion in 2019, at a CAGR of 13.0% during the forecast period. Growth in this market can be attributed to the rising prevalence of neurological disorders, efforts to develop the application base for neuromodulation, the benefits of neuroendoscopic surgeries over conventional brain surgeries, and the growing prevalence of neurological diseases. However, the high cost of neuroendoscopy procedures and equipment, along with a dearth of a trained workforce, is expected to limit market growth to a certain extent during the forecast period.
“The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018.”
On the basis of product, the neurosurgery devices market is segmented into neuromodulation devices and neuroendoscopy devices. The neuromodulation devices market is further segmented into internal neuromodulation devices and external neuromodulation devices. The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018. The large share of this segment is attributed to the rising number of neurological disorders owing to the rising geriatric population globally.
“The chronic pain applications segment will continue to dominate the spinal cord stimulation applications market during the forecast period.”
On the basis of application, the neurosurgery devices market is segmented into spinal cord stimulation, deep brain stimulation, and neuroendoscopy applications. The spinal cord stimulation applications market is further segmented into chronic pain, failed back surgery syndrome, and ischemia. The chronic pain segment accounted for the largest share of the spinal cord stimulation applications market in 2018. The large share of this segment can be attributed to the growing geriatric population and the increasing incidence of age-related neurological disorders.
“The neurosurgery devices market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
Geographically, the neurosurgery devices market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the large population in Asia (India and China account for over one-third of the global population) as well as the rising geriatric population in Asian countries.
Breakdown of supply-side primary interviews:
Research Coverage
This report studies the neurosurgery devices market based on product, application, and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the neurosurgery devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
The neurosurgery devices market is projected to reach USD 13.5 billion by 2024 from USD 7.3 billion in 2019, at a CAGR of 13.0% during the forecast period. Growth in this market can be attributed to the rising prevalence of neurological disorders, efforts to develop the application base for neuromodulation, the benefits of neuroendoscopic surgeries over conventional brain surgeries, and the growing prevalence of neurological diseases. However, the high cost of neuroendoscopy procedures and equipment, along with a dearth of a trained workforce, is expected to limit market growth to a certain extent during the forecast period.
“The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018.”
On the basis of product, the neurosurgery devices market is segmented into neuromodulation devices and neuroendoscopy devices. The neuromodulation devices market is further segmented into internal neuromodulation devices and external neuromodulation devices. The internal neuromodulation devices segment accounted for the largest share of the neuromodulation devices market in 2018. The large share of this segment is attributed to the rising number of neurological disorders owing to the rising geriatric population globally.
“The chronic pain applications segment will continue to dominate the spinal cord stimulation applications market during the forecast period.”
On the basis of application, the neurosurgery devices market is segmented into spinal cord stimulation, deep brain stimulation, and neuroendoscopy applications. The spinal cord stimulation applications market is further segmented into chronic pain, failed back surgery syndrome, and ischemia. The chronic pain segment accounted for the largest share of the spinal cord stimulation applications market in 2018. The large share of this segment can be attributed to the growing geriatric population and the increasing incidence of age-related neurological disorders.
“The neurosurgery devices market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
Geographically, the neurosurgery devices market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the large population in Asia (India and China account for over one-third of the global population) as well as the rising geriatric population in Asian countries.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25%
- By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
- By Region: North America: 20%, Europe: 25%, APAC: 40%, and the RoW: 15%
Research Coverage
This report studies the neurosurgery devices market based on product, application, and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the neurosurgery devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.2 RESEARCH APPROACH
2.2.1 RESEARCH METHODOLOGY STEPS
2.2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.2.1 Secondary research
2.2.2.2 Secondary sources
2.2.2.3 Primary research
2.2.2.4 Primary sources
2.2.2.5 Key insights from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NEUROSURGERY DEVICES: MARKET OVERVIEW
4.2 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
4.3 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
4.4 NEUROSURGERY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Research into expanding applications of neuromodulation
5.2.1.2 Benefits of neuroendoscopic surgery over conventional brain surgery
5.2.1.3 Rising prevalence of neurological diseases
5.2.2 RESTRAINTS
5.2.2.1 High cost of neuroendoscopy procedures and equipment
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.4 CHALLENGES
5.2.4.1 Dearth of trained professionals
6 NEUROSURGERY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 NEUROMODULATION DEVICES
6.2.1 INTERNAL NEUROMODULATION DEVICES
6.2.2 SPINAL CORD STIMULATION DEVICES
6.2.2.1 SCS devices dominate the internal neuromodulation devices market as they are cost-efficient
6.2.3 DEEP BRAIN STIMULATION DEVICES
6.2.3.1 Growing prevalence of Parkinson’s disease and other neurological disorders to fuel market growth
6.2.4 OTHER INTERNAL NEUROMODULATION DEVICES
6.3 EXTERNAL NEUROMODULATION DEVICES
6.3.1 RISING DEMAND FOR NONINVASIVE NEUROMODULATION TECHNIQUES TO DRIVE THE ADOPTION OF EXTERNAL NEUROMODULATION DEVICES
6.4 NEUROENDOSCOPY DEVICES
6.4.1 LOW COST, SMALLER INCISIONS, AND REDUCED HOSPITAL STAY ARE SOME OF THE ADVANTAGES ASSOCIATED WITH NEUROENDOSCOPY DEVICES
7 NEUROSURGERY DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 SPINAL CORD STIMULATION MARKET
7.2.1 CHRONIC PAIN
7.2.1.1 Spinal cord stimulation is the standard procedure for patients with chronic pain
7.2.2 FAILED BACK SURGERY SYNDROME (FBSS)
7.2.2.1 Treatments such as chiropractic and acupressure are expected to hamper the growth of the neurosurgery devices market for FBSS
7.2.3 ISCHEMIA
7.2.3.1 High incidence of ischemia to drive the demand for neurosurgery devices
7.3 DEEP BRAIN STIMULATION MARKET
7.3.1 PARKINSON’S DISEASE
7.3.1.1 Rising incidence of Parkinson’s and the growing number of researches conducted in this field to drive market growth
7.3.2 TREMOR
7.3.2.1 Rising geriatric population and the high efficacy of DBS to support market growth
7.3.3 DEPRESSION
7.3.3.1 DBS therapies to treat depression involve activating the brain directly with magnets, implants, and electricity
7.3.4 OTHER DBS APPLICATIONS
7.4 NEUROENDOSCOPY
7.4.1 TRANSNASAL NEUROENDOSCOPY
7.4.1.1 Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors
7.4.2 INTRAVENTRICULAR NEUROENDOSCOPY
7.4.2.1 Ease of use, increased visibility, and treatment of a large number of neurological conditions—key advantages of intraventricular neuroendoscopy
7.4.3 TRANSCRANIAL NEUROENDOSCOPY
7.4.3.1 Transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach
8 NEUROSURGERY DEVICES MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 The US dominates the North American neurosurgery devices market due to the high prevalence of traumatic brain injuries
8.2.2 CANADA
8.2.2.1 Favorable government initiatives to support market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 The strong presence of key neurosurgery equipment manufacturers to support market growth
8.3.2 UK
8.3.2.1 High burden of brain tumors to fuel market growth
8.3.3 FRANCE
8.3.3.1 Rising geriatric population and the associated increase in the prevalence of neurological disorders to drive the demand for neurosurgery devices
8.3.4 ROE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
9.2.1 INTRODUCTION
9.3 COMPETITIVE LEADERSHIP MAPPING
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 DYNAMIC DIFFERENTIATORS
9.3.4 EMERGING COMPANIES
9.4 COMPETITIVE SCENARIO
9.4.1 PRODUCT LAUNCHES
9.4.2 EXPANSIONS
9.4.3 ACQUISITIONS
9.4.4 JOINT VENTURES
10 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
10.1 B. BRAUN MELSUNGEN
10.2 MEDTRONIC
10.3 BOSTON SCIENTIFIC CORPORATION
10.4 NEVRO CORPORATION
10.5 KARL STORZ
10.6 ABBOTT
10.7 ACKERMANN INSTRUMENTE
10.8 ADEOR MEDICAL
10.9 HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS
10.10 MACHIDA ENDOSCOPE CO., LTD.
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.2 RESEARCH APPROACH
2.2.1 RESEARCH METHODOLOGY STEPS
2.2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.2.1 Secondary research
2.2.2.2 Secondary sources
2.2.2.3 Primary research
2.2.2.4 Primary sources
2.2.2.5 Key insights from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NEUROSURGERY DEVICES: MARKET OVERVIEW
4.2 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
4.3 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
4.4 NEUROSURGERY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Research into expanding applications of neuromodulation
5.2.1.2 Benefits of neuroendoscopic surgery over conventional brain surgery
5.2.1.3 Rising prevalence of neurological diseases
5.2.2 RESTRAINTS
5.2.2.1 High cost of neuroendoscopy procedures and equipment
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.4 CHALLENGES
5.2.4.1 Dearth of trained professionals
6 NEUROSURGERY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 NEUROMODULATION DEVICES
6.2.1 INTERNAL NEUROMODULATION DEVICES
6.2.2 SPINAL CORD STIMULATION DEVICES
6.2.2.1 SCS devices dominate the internal neuromodulation devices market as they are cost-efficient
6.2.3 DEEP BRAIN STIMULATION DEVICES
6.2.3.1 Growing prevalence of Parkinson’s disease and other neurological disorders to fuel market growth
6.2.4 OTHER INTERNAL NEUROMODULATION DEVICES
6.3 EXTERNAL NEUROMODULATION DEVICES
6.3.1 RISING DEMAND FOR NONINVASIVE NEUROMODULATION TECHNIQUES TO DRIVE THE ADOPTION OF EXTERNAL NEUROMODULATION DEVICES
6.4 NEUROENDOSCOPY DEVICES
6.4.1 LOW COST, SMALLER INCISIONS, AND REDUCED HOSPITAL STAY ARE SOME OF THE ADVANTAGES ASSOCIATED WITH NEUROENDOSCOPY DEVICES
7 NEUROSURGERY DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 SPINAL CORD STIMULATION MARKET
7.2.1 CHRONIC PAIN
7.2.1.1 Spinal cord stimulation is the standard procedure for patients with chronic pain
7.2.2 FAILED BACK SURGERY SYNDROME (FBSS)
7.2.2.1 Treatments such as chiropractic and acupressure are expected to hamper the growth of the neurosurgery devices market for FBSS
7.2.3 ISCHEMIA
7.2.3.1 High incidence of ischemia to drive the demand for neurosurgery devices
7.3 DEEP BRAIN STIMULATION MARKET
7.3.1 PARKINSON’S DISEASE
7.3.1.1 Rising incidence of Parkinson’s and the growing number of researches conducted in this field to drive market growth
7.3.2 TREMOR
7.3.2.1 Rising geriatric population and the high efficacy of DBS to support market growth
7.3.3 DEPRESSION
7.3.3.1 DBS therapies to treat depression involve activating the brain directly with magnets, implants, and electricity
7.3.4 OTHER DBS APPLICATIONS
7.4 NEUROENDOSCOPY
7.4.1 TRANSNASAL NEUROENDOSCOPY
7.4.1.1 Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors
7.4.2 INTRAVENTRICULAR NEUROENDOSCOPY
7.4.2.1 Ease of use, increased visibility, and treatment of a large number of neurological conditions—key advantages of intraventricular neuroendoscopy
7.4.3 TRANSCRANIAL NEUROENDOSCOPY
7.4.3.1 Transcranial approach is more invasive as compared to the transnasal neuroendoscopic approach
8 NEUROSURGERY DEVICES MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 US
8.2.1.1 The US dominates the North American neurosurgery devices market due to the high prevalence of traumatic brain injuries
8.2.2 CANADA
8.2.2.1 Favorable government initiatives to support market growth in Canada
8.3 EUROPE
8.3.1 GERMANY
8.3.1.1 The strong presence of key neurosurgery equipment manufacturers to support market growth
8.3.2 UK
8.3.2.1 High burden of brain tumors to fuel market growth
8.3.3 FRANCE
8.3.3.1 Rising geriatric population and the associated increase in the prevalence of neurological disorders to drive the demand for neurosurgery devices
8.3.4 ROE
8.4 ASIA PACIFIC
8.5 REST OF THE WORLD
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
9.2.1 INTRODUCTION
9.3 COMPETITIVE LEADERSHIP MAPPING
9.3.1 VISIONARY LEADERS
9.3.2 INNOVATORS
9.3.3 DYNAMIC DIFFERENTIATORS
9.3.4 EMERGING COMPANIES
9.4 COMPETITIVE SCENARIO
9.4.1 PRODUCT LAUNCHES
9.4.2 EXPANSIONS
9.4.3 ACQUISITIONS
9.4.4 JOINT VENTURES
10 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
10.1 B. BRAUN MELSUNGEN
10.2 MEDTRONIC
10.3 BOSTON SCIENTIFIC CORPORATION
10.4 NEVRO CORPORATION
10.5 KARL STORZ
10.6 ABBOTT
10.7 ACKERMANN INSTRUMENTE
10.8 ADEOR MEDICAL
10.9 HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS
10.10 MACHIDA ENDOSCOPE CO., LTD.
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 INDICATIVE LIST OF NEUROMODULATION CLINICAL TRIALS
TABLE 2 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 5 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 OTHER INTERNAL NEUROMODULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 EXTERNAL NEUROMODULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 NEUROENDOSCOPY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 SPINAL CORD STIMULATION APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 11 CHRONIC PAIN APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 FAILED BACK SURGERY SYNDROME APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 ISCHEMIA APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 15 PARKINSON’S DISEASE APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 TREMOR APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 DEPRESSION APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NEUROENDOSCOPY APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 20 TRANSNASAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 INTRAVENTRICULAR NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 TRANSCRANIAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NEUROSURGERY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 31 US: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 32 US: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 33 US: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 34 US: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 US: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 36 US: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 37 CANADA: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 38 CANADA: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 39 CANADA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 CANADA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 41 CANADA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 42 CANADA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 EUROPE: NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 45 EUROPE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 EUROPE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 EUROPE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 50 GERMANY: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 51 GERMANY: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 GERMANY: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 53 GERMANY: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 54 GERMANY: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 GERMANY: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 UK: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 57 UK: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 UK: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 59 UK: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 UK: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 61 UK: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 FRANCE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 FRANCE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 FRANCE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 FRANCE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 FRANCE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 FRANCE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 68 ROE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 69 ROE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 70 ROE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 ROE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 ROE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 ROE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 75 ASIA PACIFIC: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 ASIA PACIFIC: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 80 ROW: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 81 ROW: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 ROW: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 84 ROW: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 ROW: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 PRODUCT LAUNCHES (2017–2019)
TABLE 87 EXPANSIONS (2017–2019)
TABLE 88 ACQUISITIONS (2017–2019)
TABLE 89 JOINT VENTURES (2017–2019)
TABLE 1 INDICATIVE LIST OF NEUROMODULATION CLINICAL TRIALS
TABLE 2 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 5 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 OTHER INTERNAL NEUROMODULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 EXTERNAL NEUROMODULATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 NEUROENDOSCOPY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 SPINAL CORD STIMULATION APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 11 CHRONIC PAIN APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 FAILED BACK SURGERY SYNDROME APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 ISCHEMIA APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 15 PARKINSON’S DISEASE APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 TREMOR APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 DEPRESSION APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 OTHER DEEP BRAIN STIMULATION APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NEUROENDOSCOPY APPLICATIONS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 20 TRANSNASAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 INTRAVENTRICULAR NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 TRANSCRANIAL NEUROENDOSCOPY APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NEUROSURGERY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 28 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 31 US: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 32 US: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 33 US: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 34 US: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 US: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 36 US: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 37 CANADA: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 38 CANADA: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 39 CANADA: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 CANADA: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 41 CANADA: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 42 CANADA: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 EUROPE: NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 45 EUROPE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 EUROPE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 EUROPE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 50 GERMANY: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 51 GERMANY: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 GERMANY: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 53 GERMANY: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 54 GERMANY: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 GERMANY: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 UK: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 57 UK: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 UK: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 59 UK: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 60 UK: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 61 UK: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 FRANCE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 63 FRANCE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 64 FRANCE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 FRANCE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 FRANCE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 FRANCE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 68 ROE: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 69 ROE: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 70 ROE: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 ROE: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 ROE: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 ROE: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 75 ASIA PACIFIC: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76 ASIA PACIFIC: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 80 ROW: NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 81 ROW: NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 ROW: NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 84 ROW: NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 ROW: NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY APPLICATIONS, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 PRODUCT LAUNCHES (2017–2019)
TABLE 87 EXPANSIONS (2017–2019)
TABLE 88 ACQUISITIONS (2017–2019)
TABLE 89 JOINT VENTURES (2017–2019)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN: NEUROSURGERY DEVICES MARKET
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 NEUROSURGERY DEVICES MARKET: BOTTOM-UP APPROACH
FIGURE 4 NEUROSURGERY DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 7 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE NEUROSURGERY DEVICES MARKET
FIGURE 10 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH
FIGURE 11 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024
FIGURE 12 PARKINSON'S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018
FIGURE 13 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
FIGURE 14 NEUROSURGERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NEUROMODULATION DEVICES TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
FIGURE 16 SPINAL CORD STIMULATION DEVICES SEGMENT DOMINATES THE INTERNAL NEUROMODULATION DEVICES MARKET
FIGURE 17 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024
FIGURE 18 PARKINSON'S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018
FIGURE 19 TRANSCRANIAL NEUROENDOSCOPY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE NEUROENDOSCOPY APPLICATIONS MARKET
FIGURE 20 NORTH AMERICA DOMINATES THE NEUROSURGERY DEVICES
FIGURE 21 NORTH AMERICA: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 22 EUROPE: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 24 ROW: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS IN THE NEUROSURGERY DEVICES MARKET, 2017–2019
FIGURE 26 NEUROENDOSCOPY: MARKET SHARE RANKING, BY KEY PLAYER (2018)
FIGURE 27 NEUROMODULATION: MARKET SHARE RANKING, BY KEY PLAYER (2018)
FIGURE 28 NEUROSURGERY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
FIGURE 29 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2018)
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2018)
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 32 NEVRO CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2018)
FIGURE 1 RESEARCH DESIGN: NEUROSURGERY DEVICES MARKET
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 NEUROSURGERY DEVICES MARKET: BOTTOM-UP APPROACH
FIGURE 4 NEUROSURGERY DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 7 NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE NEUROSURGERY DEVICES MARKET
FIGURE 10 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH
FIGURE 11 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024
FIGURE 12 PARKINSON'S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018
FIGURE 13 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
FIGURE 14 NEUROSURGERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NEUROMODULATION DEVICES TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
FIGURE 16 SPINAL CORD STIMULATION DEVICES SEGMENT DOMINATES THE INTERNAL NEUROMODULATION DEVICES MARKET
FIGURE 17 CHRONIC PAIN SEGMENT WILL CONTINUE TO DOMINATE THE SPINAL CORD STIMULATION APPLICATIONS MARKET IN 2024
FIGURE 18 PARKINSON'S DISEASE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE DEEP BRAIN STIMULATION APPLICATIONS MARKET IN 2018
FIGURE 19 TRANSCRANIAL NEUROENDOSCOPY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE NEUROENDOSCOPY APPLICATIONS MARKET
FIGURE 20 NORTH AMERICA DOMINATES THE NEUROSURGERY DEVICES
FIGURE 21 NORTH AMERICA: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 22 EUROPE: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 24 ROW: NEUROSURGERY DEVICES MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS IN THE NEUROSURGERY DEVICES MARKET, 2017–2019
FIGURE 26 NEUROENDOSCOPY: MARKET SHARE RANKING, BY KEY PLAYER (2018)
FIGURE 27 NEUROMODULATION: MARKET SHARE RANKING, BY KEY PLAYER (2018)
FIGURE 28 NEUROSURGERY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
FIGURE 29 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2018)
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2018)
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 32 NEVRO CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2018)
